The DFID-CHAI Market Shaping programme focused on increasing access to safe, effective and affordable commodities to support priority health care interventions in developing countries. At the logframe Impact level, the DFID grant was expected to contribute to the health-related MDGs by leveraging savings achieved towards increased testing and treatment for key conditions. At the Outcome level, the grant aimed to facilitate access to, and quality of, treatment of more patients within current funding levels. This was to be achieved by reducing the cost of health commodities and delivery and increasing the availability of more affordable commodities (both number and amount procured) originating from low-cost, high-quality manufacturing environments such as China and India.
The DFID grant ran for three years (2012-2015) and supported CHAI’s work in nine programme areas, five of which have been evaluated:
- Maximising Value for Money and Ensuring Sustainable Supply of HIV Treatment
- Accelerating Introduction and Scale-Up of Point-of-Care (PoC) HIV Diagnostics
- Maximising Value for Money of HIV Spending for Universal Access to Antiretroviral Therapy (ART) (known as “E2” and being reviewed separately)
- Increasing Access to Long-Acting Reversible Contraceptives (LARCs)
- Ensuring Rapid and Sustainable Scale-Up of Supply of Quality Malaria Treatments
This is the final report from the evaluation and includes an overview of the programme and area findings.
